Adverse events among persons with TB using in-person vs. electronic directly observed therapy
Supporting Files
-
8 01 2023
-
File Language:
English
Details
-
Alternative Title:Int J Tuberc Lung Dis
-
Personal Author:
-
Description:BACKGROUND :
We evaluated patient safety within a randomized crossover trial comparing electronic directly observed therapy (eDOT) to in-person DOT (ipDOT) in persons undergoing TB treatment in New York City, NY, USA.
METHODS :
Participant symptoms, symptom severity, and clinical management were documented. We assessed adverse event reports (AERs) by DOT method during the two-period crossover. Using Cox proportional-hazards mixed-effects models, we estimated the adjusted hazard ratio (aHR) of participants reporting an adverse event (AE) vs. not reporting an AE.
RESULTS :
Of 211 participants, 57 (27.0%) reported AEs during the two-period crossover; of these, 54.4% (31/57) were reported while using eDOT vs. 45.6% (26/57) while using ipDOT. Controlling for study group and period, the aHR for eDOT vs. ipDOT was 0.98 (95% CI 0.49–1.93). Although statistically not significant, the wide confidence intervals suggest that a significant association cannot be entirely ruled out. Gastrointestinal symptoms were most frequently reported (42.1%, 24/57). AER types and severity did not differ significantly by DOT method. Days from symptom onset to medical attention was similar across DOT methods (median: 1.0 day, IQR 0.0–2.0). No participants switched DOT methods due to AERs or monitoring concerns.
CONCLUSION :
Further evaluation to ascertain whether AERs differ when patients use eDOT vs. ipDOT is warranted.
-
Subjects:
-
Keywords:
-
Source:Int J Tuberc Lung Dis. 27(11):833-840
-
Pubmed ID:37880884
-
Pubmed Central ID:PMC10794055
-
Document Type:
-
Funding:
-
Volume:27
-
Issue:11
-
Collection(s):
-
Main Document Checksum:urn:sha-512:4b1ef713d36626e57a8f2f716c648a5abd99e9227933e076e55b6b32b8f6db706e373c5cd107fc51e688d66fdcfbb2a51f71033abba7b3c40ee7f12bc496b5ff
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access